Black AIDS Institute Applauds FDA Approval Of PrEP

    The Black AIDS Institute recently announced its support of the FDA’s decision to approve use of the antiretroviral drug Truvada as an option for HIV prevention.

    Gilead Sciences, maker of Truvada, based its application on results of two placebo-controlled trials-iPrEx in men who have sex with men and Partners PrEP in HIV-discordant heterosexual African couples.

    Celebrate great health! LIKE on Facebook!

    1 2Next page »


    Get every new post delivered to your Inbox.

    Join 2,464 other followers